Endocyte Inc. (ECYT) News Nov 20, 2014, 5:14 p.m.
Post# of 250602
MarketWatch News on ECYT
Merck, Endocyte halt study of ovarian cancer drug 8:32 a.m. May 2, 2014 - MarketWatch.com
Charting the April cross currents 11:20 a.m. April 10, 2014 - Michael Ashbaugh
Six charts to watch for upside moves 12:33 p.m. March 28, 2013 - The Trading Deck
J&J to supply additional Doxil for clinical trials 11:16 a.m. Aug. 2, 2012 - MarketWatch.com
Endocyte shares extend gains in after-hours trade 4:50 p.m. April 16, 2012 - Carla Mozee
Stocks to watch Tuesday: Coke, Goldman Sachs 4:32 p.m. April 16, 2012 - David B. Wilkerson
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Endocyte soars 101% on Merck deal 10:43 a.m. April 16, 2012 - Val Brickates Kennedy
Merck to pay Endocyte up to $1 bln for cancer drug 6:57 a.m. April 16, 2012 - MarketWatch.com
Endocyte rockets 60% on EU update 12:09 p.m. March 14, 2012 - Val Brickates Kennedy
Endocyte plunges on drug study results 11:48 a.m. Dec. 13, 2011 - Val Brickates Kennedy
LinkedIn's surge sparks valuation questions 1:28 p.m. May 19, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:00 p.m. April 26, 2011 - Kate Gibson
Other News on ECYT
Can Endocyte (ECYT) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape 8:46 a.m. Today - Zacks.com
10-Q: ENDOCYTE INC 4:09 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% - Tale of the Tape 9:18 a.m. Nov. 7, 2014 - Zacks.com
Endocyte's (ECYT) CEO Ron Ellis on Q3 2014 Results - Earnings Call Transcript 10:52 p.m. Nov. 5, 2014 - Seeking Alpha
Endocyte (ECYT) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 5, 2014 - Seeking Alpha
Notable earnings after Wednesday’s close 5:35 p.m. Nov. 4, 2014 - Seeking Alpha
Will Endocyte (ECYT) Miss This Earnings Season? - Analyst Blog 4:50 p.m. Nov. 4, 2014 - Zacks.com
Endocyte's vintafolide shows mixed results in Phase 2 trial 5:45 p.m. Oct. 1, 2014 - Seeking Alpha
Why Endocyte (ECYT) Stock Is Declining Today 11:44 a.m. Sept. 30, 2014 - TheStreet.com
Brean Capital Downgrades Endocyte To Hold 7:34 a.m. Sept. 30, 2014 - benzinga.com
Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog 5:25 p.m. Sept. 29, 2014 - Zacks.com
Heavy Trading On Endocyte (ECYT) Before Market Open 8:32 a.m. Sept. 29, 2014 - TheStreet.com
Endocyte (ECYT) Flagged As Strong On High Volume 10:01 a.m. Sept. 23, 2014 - TheStreet.com
Palo Alto Networks Adds Stanley J. Meresman To Its Board 3:04 p.m. Sept. 22, 2014 - benzinga.com
Endocyte (ECYT) Showing Signs Of A Dead Cat Bounce Today 9:55 a.m. Sept. 19, 2014 - TheStreet.com
Top Swing Trade Ideas for Monday: Cerus, Endocyte, More 10:02 a.m. Sept. 15, 2014 - TheStreet.com
Endocyte (ECYT) Showing Signs Of A Dead Cat Bounce Today 10:08 a.m. Sept. 12, 2014 - TheStreet.com
Endocyte (ECYT) Showing Signs Of Perilous Reversal Today 9:46 a.m. Sept. 11, 2014 - TheStreet.com
Strength Seen in Flexion Therapeutics (FLXN): Stock Soars 17.8% - Tale of the Tape 9:46 a.m. Sept. 11, 2014 - Zacks.com
Aradigm Corporation (ARDM) Up: Stock Adds 9.7% in Session - Tale of the Tape 9:32 a.m. Sept. 11, 2014 - Zacks.com
Press Releases on ECYT
Endocyte Reports Third Quarter Financial Results and Provides Clinical Update 4:02 p.m. Nov. 5, 2014 - GlobeNewswire
Endocyte to Present at the 2014 Credit Suisse Healthcare Conference 4:04 p.m. Nov. 4, 2014 - GlobeNewswire
Endocyte Announces Third Quarter 2014 Earnings Conference Call 3:03 p.m. Oct. 29, 2014 - GlobeNewswire
Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte 8:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide 9:15 a.m. Sept. 27, 2014 - GlobeNewswire
Endocyte Announces Late-Breaking Abstract Presentation at the European Society for Medical Oncology (ESMO) Conference 3:02 p.m. Sept. 22, 2014 - GlobeNewswire
Critical Alerts For Weibo, Williams Companies, Endocyte, Boulder Brands and Randgold Resources Released By InvestorsObserver 8:31 a.m. Sept. 10, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry - Zoetis, Actavis, Horizon Pharma, Hospira, and Endocyte 7:55 a.m. Sept. 9, 2014 - PR Newswire - PRF
Endocyte to Present at the Baird 2014 Health Care Conference 3:02 p.m. Aug. 27, 2014 - GlobeNewswire
UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Endocyte, Inc. and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 9:31 a.m. Aug. 20, 2014 - GlobeNewswire
Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., EVOQ Properties Inc., Fortegra Financial Corporation, Intervest Bancshares Corporation and L-3 Communications Holdings, Inc. 12:52 p.m. Aug. 18, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Endocyte, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ECYT 12:49 p.m. Aug. 18, 2014 - GlobeNewswire
ENDOCYTE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endocyte, Inc. -- ECYT 9:00 p.m. Aug. 14, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Endocyte, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 4:47 p.m. Aug. 13, 2014 - GlobeNewswire
Endocyte Announces Presentations at the 248th American Chemical Society National Meeting & Exposition 3:04 p.m. Aug. 7, 2014 - GlobeNewswire
Endocyte to Present at Wedbush 2014 Life Sciences Management Access Conference 3:02 p.m. Aug. 5, 2014 - GlobeNewswire
Lieff Cabraser Announces Class Action Litigation Against Endocyte, Inc. - ECYT 2:54 p.m. Aug. 1, 2014 - BusinessWire - BZX
Critical Alerts For Aegerion Pharmaceuticals, ZELTIQ Aesthetics, Endocyte, Broadcom, and AstraZeneca Released By InvestorsObserver 8:31 a.m. July 31, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In Endocyte, Inc. To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit 3:59 p.m. July 30, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Endocyte, Inc. and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 4:55 p.m. July 29, 2014 - GlobeNewswire